188 related articles for article (PubMed ID: 24363502)
1. Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.
Tomić M; Ljubić S; Kaštelan S; Gverović Antunica A; Jazbec A; Poljičanin T
Mediators Inflamm; 2013; 2013():818671. PubMed ID: 24363502
[TBL] [Abstract][Full Text] [Related]
2. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.
Tomić M; Ljubić S; Kastelan S
Coll Antropol; 2013 Apr; 37 Suppl 1():51-7. PubMed ID: 23837221
[TBL] [Abstract][Full Text] [Related]
3. Differential Association of Generalized and Abdominal Obesity With Diabetic Retinopathy in Asian Patients With Type 2 Diabetes.
Man RE; Sabanayagam C; Chiang PP; Li LJ; Noonan JE; Wang JJ; Wong TY; Cheung GC; Tan GS; Lamoureux EL
JAMA Ophthalmol; 2016 Mar; 134(3):251-7. PubMed ID: 26720805
[TBL] [Abstract][Full Text] [Related]
4. Body mass index: a risk factor for retinopathy in type 2 diabetic patients.
Kaštelan S; Tomić M; Gverović Antunica A; Ljubić S; Salopek Rabatić J; Karabatić M
Mediators Inflamm; 2013; 2013():436329. PubMed ID: 24347825
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.
Rajalakshmi R; Behera UC; Bhattacharjee H; Das T; Gilbert C; Murthy GVS; Pant HB; Shukla R;
Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S21-S26. PubMed ID: 31937724
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation and dyslipidemia are associated with retinopathy in type 2 but not in type 1 diabetes.
Tomić M; Vrabec R; Vidas Pauk S; Bulum T; Ljubić S
Scand J Clin Lab Invest; 2020 Oct; 80(6):484-490. PubMed ID: 32644839
[TBL] [Abstract][Full Text] [Related]
7. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
[TBL] [Abstract][Full Text] [Related]
9. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
[TBL] [Abstract][Full Text] [Related]
10. Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic Patients.
Chen J; Wan Y; Su J; Zhu Z; Pan E; Shen C; Wen J; Wang K; Yu H; Qin Y; Cui L; Zhou J; Wu M
Acta Diabetol; 2022 Mar; 59(3):359-367. PubMed ID: 34713323
[TBL] [Abstract][Full Text] [Related]
11. The Use of Anthropometric Measurements of Obesity in Prediction of Microvascular Complications in Obese Type 2 Diabetic Patients.
Bulum T; Blaslov K; Duvnjak L
Acta Clin Croat; 2016 Jun; 55(2):217-23. PubMed ID: 28394108
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Circulating Biomarkers in Relation to Various Stages of Diabetic Retinopathy in Type 2 Diabetic Patients-A Cross Sectional Study.
Mathala N; Akula A; Hegde S; Bitra R; Sachedev V
Curr Diabetes Rev; 2020; 16(4):402-409. PubMed ID: 31441730
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
14. Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.
Chen L; Zhang X; Wen F
Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1059-1065. PubMed ID: 29626228
[TBL] [Abstract][Full Text] [Related]
15. Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.
Crosby-Nwaobi R; Chatziralli I; Sergentanis T; Dew T; Forbes A; Sivaprasad S
J Diabetes Res; 2015; 2015():191382. PubMed ID: 26295054
[TBL] [Abstract][Full Text] [Related]
16. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
17. Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes.
Wang J; Xin X; Luo W; Wang R; Wang X; Si S; Mo M; Shao B; Wang S; Shen Y; Chen X; Yu Y
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):25. PubMed ID: 33351059
[TBL] [Abstract][Full Text] [Related]
18. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy.
Ergün UG; Oztüzün S; Seydaoglu G
Med J Malaysia; 2004 Aug; 59(3):406-10. PubMed ID: 15727389
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea.
Hwang IC; Bae JH; Kim JM
Eye (Lond); 2019 Jun; 33(6):980-987. PubMed ID: 30760896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
